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Background: The HIV/AIDS infection is common in sub-Saharan Africa and is associated with psychological and
neuro- cognitive impairment. These conditions, however, remain largely unrecognized. In this study we aimed to
determine the prevalence of probable HIV dementia (PHD) in an HIV clinic population in Uganda and to delineate
the factors associated with such impairment in these HIV positive individuals.
Methods: Six hundred eighty HIV clinic attendees were surveyed in a cross sectional study. PHD was assessed
using the International Dementia Scale (IHDS). Standardized measures were also used to assess clinical,
psychological, social and demographic variables. Respondents were aged 18 years and above and did not have
severe physical or mental health conditions. Multivariate analysis was conducted to identify associations between
PHD and various factors.
Results: The prevalence of probable HIV dementia was 64.4%. PHD was significantly associated with increasing
stress scores and psychosocial impairment but not with age, BMI, CD4 count, use of HAART, or a diagnosis of
depression or alcohol dependence.
Conclusion: The prevalence of probable HIV dementia in an ambulatory adult HIV positive population in Uganda
was 64.4%. Increasing stress scores and psychosocial impairment were significant contributing factors. Clinicians
need to be aware of this and to make efforts to identify neuro-cognitive impairment. Secondly there is need for
more studies to better understand the relationship between PHD and stress in HIV populations so as to inform
patient care.
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The Human Immuno Deficiency Virus (HIV) infection
that causes the Acquired Immuno-deficiency Syndrome
(AIDS) is prevalent in Africa with eighty percent of HIV
positive people worldwide living on the continent, des-
pite the continent constituting only 11–12% of the
world’s population [1]. Africa shoulders 75% of the
world’s burden of AIDs related deaths [1]. Neuro-
cognitive impairment (NCI) in HIV/AIDS remains
largely unrecognized especially in sub-Saharan Africa
mainly because providers lack the expertise to identify it* Correspondence: jnakku@yahoo.com
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reproduction in any medium, provided the orbut also because it is not routinely screened for, despite
this recommendation in HIV treatment guidelines [2].
Medical conditions such as chronic depression and
neuro-cognitive impairment have been associated with
impaired cell- mediated immunity and increased morta-
lity among individuals with HIV/AIDS irrespective of
their clinical stage, CD4 count or use of highly active
anti-retroviral therapy (HAART) [3]. HIV related NCI
occurs on a spectrum ranging from, according to
Antinori et al. [4], asymptomatic neuropsychological im-
pairment to mild neuro cognitive disorder (cognitive im-
pairment with mild functional impairment) to frank HIV
associated Dementia (marked cognitive impairment and
marked functional impairment).td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Nakku et al. BMC Psychiatry 2013, 13:126 Page 2 of 7
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probable HIV dementia (PHD) among an ambulant HIV
clinic population in Entebbe, Uganda. In addition we
sought to delineate the factors associated with PHD in
these HIV positive individuals.
Methods
Study design
This was a cross sectional study undertaken at two HIV
clinics in the semi-urban district of Entebbe, Uganda. All
consenting eligible HIV-infected patients attending the
two HIV clinics in the government health facilities of
Entebbe District Hospital and Kigungu Health Centre III
were continuously enrolled into this study. To be eligible
for inclusion in this study an individual had to be regis-
tered with the study HIV clinics, be aged 18 years and
above, be fluent in English or Luganda (the local lan-
guage into which the study instruments had been
translated) and not be too physically and mentally
sick, as determined by the attending clinician, to un-
dertake the interview. Trained psychiatric nurses recruited
from Uganda’s national psychiatric referral hospital at
Butabika conducted the structured interviews.
Data collection tools
The data collection tool consisted of structured and stan-
dardized modules which were translated into Luganda
and back translated to English by two independent bilin-
gual psychologists. Meetings were held with the transla-
tors in order to obtain consensus. The tools included a
social demographic questionnaire, The international HIV
dementia Scale (IHDS) [5], the Mini neuropsychiatric in-
terview (M.I.N.I plus) [6], a negative coping style index
[7], a negative life events score index [7],a stress score
index [7].
The Socio-demographic questionnaire identified sex,
age, marital status, highest educational attainment, reli-
gion, and employment status and various social factors
such as food insecurity, distance from the HIV clinic and
duration of awareness of HIV status. Clinical factors
assessed included the most recent CD4 count, body
mass index (BMI), probable HIV dementia and psychia-
tric diagnoses.
The International HIV Dementia Scale (IHDS) [5]
scale was used for measuring probable HIV dementia.
This is a bed side screening tool for HIV associated de-
mentia. It can be used in a clinic setting and only re-
quires 2–3 minutes to complete. This tool has been
validated in South Africa and Uganda and found to have
good psychometric properties in African populations
with sensitivity of 88% and 80% and specificity of 50%
and 55% respectively at a cut off of 10 or less [5,8]. This
tool that assesses for memory impairment, motor and
psychomotor speed does not require one to be proficientin English and is brief and inexpensive. Even though it is
thought not to be ideal, it is one of the best for use
across cultures for screening for neuro-cognitive impair-
ment in HIV [5].
The M.I.N.I. neuropsychiatric interview (MINI Plus)
[6] is a modular DSM IV based structured interview for
the diagnosis of psychiatric disorder. The psychiatric dis-
order modules used in this study were for major depres-
sive disorder, suicidality, alcohol use disorders, generalized
anxiety disorder and post-traumatic stress disorder.
Negative coping style index [7] was constructed from
variables of the Mental Adjustment to Cancer Scale
(MAC) [9] whose items had been adapted to the local
HIV situation [7]. Each of this scale’s 17 questionnaire
items is scored on a 4-item likert scale 1= (definitely
does not apply to me), 2= (does not apply to me),
3= (applies to me), 4= (definitely applies to me). To
score all the questionnaire items so that they are all in
the same direction i.e. higher scores reflecting more
negative coping style required that questionnaire items
(1,4,5,10,11,12, 13, 15, 16) that are cast positively be re-
verse scored. For instance item 1: ‘I have been doing
things that I believe will improve my health e.g. changed
my diet. A total score was generated so that higher scores
reflected a more negative coping style. The Cronbach’s α
of this scale in this study was 0.58.
Negative life events score index [7] was constructed
from items of the adverse life events module of the
European Para-suicide Interview Schedule (EPSIS I) [10]
that has previously been modified for the Ugandan situ-
ation by Kinyanda and colleagues (2005) [11]. For this
study respondents were required to report whether they
had experienced each of these events in the last 6
months. Items that were selected for inclusion in this
study were those that were thought to be relevant to the
HIV social situation in Uganda. The negative life events
considered in this study looked at bereavement, severe
illness and severe interpersonal conflict in the following
significant social relationships; parent, sibling, spouse/
lover and child(ren). The individual related negative life
events considered in this study examined for severe sick-
ness, interpersonal conflict, feelings of isolation and
abandonment, lack of the basic requirements of food,
shelter and medicine. Others included job loss, discrim-
ination and worries about personal finances. A total
score was generated to reflect the total number of life
events reported. This scale had a Cronbach’s α of 0.82 in
this study.
The Stress Score index [7] was constructed by scoring
each of the reported negative life events on a 3 point
likert scale where respondents were asked the question,
‘how stressful did you find the event?’ with possible
responses being: 0=(not stressing/minimal stressing),
1=(moderately stressing), 2=(severely stressing). A total
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stress.
Statistical analysis
Statistical analysis was undertaken using both SPSS ver-
sion 9.05 (reliability tests) and STATA. Logistic regres-
sion models were used to assess univariate associations
between the dependent variable (probable HIV dementia-
PHD) and independent variables, grouped in sets of de-
mographic, social, clinical and psychological risk factors,
with unadjusted and adjusted odds ratio (adjusted for sex
and age) reported. After adjusting within each set of risk
factors, those that were associated with PHD at a level of
significance of 0.1 were entered into a multivariable model
to determine their independent effect on PHD. Factors
which remained associated with PHD at p<0.05 were
retained in the final model.
Ethical considerations
The study obtained ethical approval from the Uganda

















No education 65 (10.5)
Primary only 289 (46.8)







Tradesperson/artisan/transport worker 262 (42.4)
Unemployed/house Wife 131 (21.2)
Others (including students) 84 (13.6)
Note:§ Adjusted for age and sex.the Uganda National Council of Science and Technology
and the London School of Hygiene Ethics Committee.
Study participants were invited to consent after being
provided with adequate information about the study. Re-
spondents found to have significant psychiatric problems
were referred to the psychiatric department at Entebbe
district hospital for further assessment and management.
Results
Study population
From 6th May 2010 to 10th August 2010, 680 patients
attending the HIV clinics at Entebbe hospital and
Kigungu health centre III were screened and given ap-
pointments to be interviewed for this study. Of these
618 (90.9%) were eventually enrolled into the study
while 62 (9.1%) failed to turn up for their interview ap-
pointment even after being repeatedly contacted by tele-
phone. Those who refused to participate in this study
did not differ significantly from those who were enrolled
into the study on gender and age. Of those who were en-









291 (64.8) 1.12 (0.78-1.62)
P=0.927
36 (62.1) 1
150 (63.0) 1.04 (0.58-1.88)
147 (67.7) 1.28 (0.70-2.34)
62 (60.2) 0.92 (0.48-1.79)
P=0.669 P=0.592
188 (63.1) 1 1
54 (65.1) 1.09 (0.65-1.81) 1.12 (0.65-1.94)
104 (72.7) 1.56 (1.01-2.41) 1.56 (0.99-2.44)
49 (52.7) 0.65 (0.41-1.04) 0.63 (0.39-1.02)
P=0.276 P=0.246
45 (69.2) 1 1
187 (64.7) 0.81 (0.46-1.45) 0.84 (0.47-1.50)
164 (62.1) 0.73 (0.41-1.30) 0.73 (0.40-1.31)
P=0.081 P=0.167
336 (62.8) 1 1
59 (72.8) 1.59 (0.94-2.67) 1.60 (0.94-2.70)
P=0.009 P=0.006
67 (69.1) 1 1
29 (67.4) 0.93 (0.43-2.00) 0.87 (0.41-1.90)
174 (66.4) 0.88 (0.54-1.46) 0.86 (0.51-1.44)
85 (64.9) 0.83 (0.47-1.45) 0.78 (0.43-1.42)
40 (47.6) 0.41 (0.22-0.75) 0.40 (0.21-0.73)
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contributed 87 (14.1%).
Like in many HIV clinics in sub-Saharan Africa, the
majority of respondents were female (449, 72.7%). Eighty
three percent were less than 45 years of age. The popu-
lation served by the two health centers was similar in
terms of gender and age. The majority of respondents
(354, 57.3%) had little (less than 8 years) or no formal
education. The prevalence of probable HIV dementia as
evidenced by a score of ≤10 on the IHDS was 64.4%
(95%CI, 60.3%-67.9%).
Two hundred and ninety one (291, 64.8%) of all the fe-
male respondents and 105 (62.1%) of the male respon-
dents were positive for PHD. There was no statistically
significant difference between the gender on this var-
iable. Age was not associated with PHD nor was ma-
rital status nor level of highest educational attainment
(Table 1).
Table 2, eight percent (50, 8%) of our respondents
had a MINI-plus diagnosable major depressive dis-
order. The majority of these, (30, 60.6%) had PHD i.e.
scored ≤10 on the IHDS. A diagnosis of common mental
disorder including major depressive disorder, alcohol de-
pendence, generalized anxiety disorder and post traumatic
stress disorder did not show association with PHD.Table 2 Clinical risk factors by probable HIV dementia (PHD)
Clinical condition Number in
study (N,%)
Diagnosis of post traumatic stress disorder
Present 10 (1.6)



















Note:§ Adjusted for age and sex.About two thirds (399, 64.6%) of all respondents were
on HAART with the majority (456, 75.2%) having been
on HAART for more than 12 months. Of these 64.1%
scored ≤10 on the IHDS signifying PHD. However, there
was no statistical significant association between PHD
and being on HAART. The median CD4 count in this
study was 300cells/μL. Of the two clinical parameters
BMI and recent CD4 count (last 6 months), only recent
CD4 count almost attained a significant association with
PHD (Table 3).
Of the psychosocial factors assessed the following were
associated with PHD: an increasing number of negative
life events i.e. 6–10 events (aOR=2.14; 95% CI= 1.45-
3.15); and 11+ events (aOR =2.35, 95% CI= 1.33-4.13) as
compared to having 1–5 negative life events. Increas-
ing stress scores i.e.medium stress scores (aOR=2.55;
95% CI 1.73-3.77); and high stress scores (aOR=3.29,
95% CI=1.99-5.45) as compared to having low stress
scores. Psychosocial impairment was significantly as-
sociated with PHD (aOR=0.45, 95% CI= 0.32-0.64) but
not negative coping style.
Factors associated with PHD at multivariate analysis
When a multivariate analysis model was constructed,







8 (80.0) 2.27 (0.48-10.8) 2.28 (0.48-10.91)
P=0.166 P=0.5730
5 (100) P=0.559 P= 0.5309
P=0.561 P=0.573
2 (50.0) 0.56 (0.08-3.99) 0.56 (0.08-4.11)
P=0.531 P=0.514
30 (60.0) 0.83 (0.46-1.49) 0.82 (0.45-1.49)
P=0.088 P=0.061
52 (78.8) 1 1
105 (66.0) 0.52 (0.27-1.03) 0.52 (0.26-1.03)
46 (56.8) 0.35 (0.17-0.74) 0.34 (0.16-0.72)
142 (64.6) 0.49 (0.26-0.94) 0.47 (0.24-0.91)
P=0.205 P=0.166
32 (57.1) 1 1
262 (67.5) 1.56 (0.88-2.76) 1.58 (0.88-2.81)
65 (55.6) 0.94 (0.49-1.78) 0.93 (0.48-1.80)
20 (57.1) 1.00 (0.42-2.35) 0.93 (0.38-2.24)
P=0.559 P=0.5309
259 (64.1) 1.11 (0.79-1.56) 1.09 (0.76-1.58)
137 (62.6) 1 1
Table 3 Psychosocial risk factors by probable HIV dementia (PHD)
Number in study (N,%) Probable HIV dementia (n,%) Unadjusted OR (95% CI) Adjusted OR§ (95% CI)
Social Support P=0.644 P=0.179
Low 188 (30.4) 123 (65.4) 1.09 (0.76-1.56) 1.1. (0.76-1.59)
High 430 (69.6) 273 (63.5) 1 1
Negative life events P<0.001 P<0.001
1-5 events 350 (56.6) 199 (56.9) 1 1
6-10 events 191 (43.7) 138 (72.8) 2.03 (1.38-2.97) 2.14 (1.45-3.15)
11 + 77 (12.5) 58 (74.3) 2.32 (1.32-4.05) 2.35 (1.33-4.13)
Stress Score index P<0.001 P<0.001
Low (score 0) 164 (26.5) 77 (46.9) 1 1
Medium (score 1–10) 323 (52.3) 222 (68.7) 2.48 (1.69-3.65) 2.55 (1.73-3.77)
High (score>10) 131 (21.2) 97 (74.0) 3.22 (1.96-5.30) 3.29 (1.99-5.45)
Negative Coping Style index P=0.554 P=0.606
Low 101 (16.3) 81 (80.2) 1 1
Medium 322 (52.1) 160 (52.5) 0.27 (0.16-0.47) 0.26 (0.15-0.44)
High 195 (31.6) 146 (74.9) 0.74 (0.41-1.32) 0.71 (0.39-1.28)
Psychosocial Impairment P=<0.001 P=<0.001
Present 318 (51.5) 176 (55.3) 0.45 (0.32-0.63) 0.45 (0.32-0.64)
Note: § Adjusted for age and sex.
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None of the demographic characteristics or clinical fac-
tors studied (either psychiatric or physical) was signifi-
cantly associated with PHD at multivariate analysis.
Discussion
Although the prevalence of PHD in HIV has been
reported to range from 12% - 56% using a range of
neuropsychiatric batteries [12-14], sub-Saharan Africa
contributes very little to this body of knowledge. This
study attempts to address this problem. Nakasujja et al.
[15] found a prevalence of IHDS identified PHD to be
68.6% in a cohort of highly selected HIV+ adults not yet
started on HAART. In our study the prevalence of IHDS
identified PHD was very similar (64.4%) in an adult HIV
clinic population the majority of whom (75.2%) were onTable 4 Final multivariate model of risk factors for
probable HIV dementia
(95% CI)
Negative life events P=0.344
1-5 events 1
6-10 events 1.45 (0.88-2.40)
11 + 1.95 (0.78-4.86)
Stress Score index P=0.013
Score 0 1
Score 1-10 1.99 (1.28-3.09)
Score >10 1.83 (0.80-4.16)
Psychosocial Impairment P<0.001
Present 0.43 (0.31-0.61)HAART. This underlines the absence of association be-
tween use of HAART and IHDS identified PHD in HIV/
AIDS individuals in Uganda. This probably points to the
fact that HAART in Uganda like in many other sub-
Saharan African settings is initiated late or that the re-
gimens used have poor penetration of the blood brain
barrier and therefore low capacity to prevent the occur-
rence of HIV dementia.
Social demographic correlates
The association between PHD and advanced age has
been described before [12-16]. In this study this asso-
ciation between PHD and age was not demonstrated.
Ordinarily neuro-cognitive performance declines with
increasing age even without the additional risk of HIV.
This decline however is known to occur beyond age 50
years. In our study the majority of the respondents were
below 45 years of age (83.3%) which may have been the
reason for the absence of association between older age
and PHD. The lack of association between PHD and
education level confirms the suitability of the constructs
within the IHDS which are not dependent on the educa-
tional status of an individual.
Clinical correlates
The rate of depression symptoms among individuals
with PHD in Ugandan HIV+ adult populations is high
[15]. Depression presents with cognitive symptoms such
as concentration and memory difficulties [17] but also
has been reported to be the first sign of neuro-cognitive
impairment or to make NCI worse [13,18]. Our study
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depressive disorder. Similar findings have been reported
by other researchers [19].
In this study PHD was only marginally associated with
recent CD4 count at bivariate analysis. A significant as-
sociation between recent CD4 count and PHD has previ-
ously been demonstrated by earlier researchers [12,13].
Usually a low CD 4 count is used as a marker of HIV
disease progression and this has previously been found
to be associated with declining cognitive performance.
The relationship between PHD and most recent CD4
count is however, is not a fore gone conclusion as some
studies have not reported this association [16]. The vari-
ability of results in this area could be attributed to many
factors including differences in the elements of NCI
measured, the severity of impairment i.e. HIV associated
dementia as opposed to mild neuro- cognitive disorder
or both and in the variety of measurement tools.
Psychosocial correlates
It has been argued that stress, coping, social support and
life events may be related to HIV disease progression
[19]. There are however few studies into the association
of these factors with neuro-cognitive impairment in HIV
[20]. This study is one of the few that demonstrates this
association. It would be tempting to attribute the associ-
ation between stress and PHD to advanced HIV disease.
However, the lack of a significant association between
PHD and CD4 count in this study (a marker of HIV dis-
ease progression) points to a more complex relationship
between these variables and PHD which this study was
not designed to elucidate. Further research into this area
is therefore required.
Limitations of this study
The International HIV Dementia Scale used to measure
PHD in this study is a screening tool for HIV dementia
not a diagnostic assessment tool. For this reason, in this
study we report on ‘probable HIV dementia’ (PHD) and
not on a diagnosis of ‘HIV dementia’. However this tool
has previously been validated to screen for HIV demen-
tia in the Ugandan situation with good psychometric
properties observed during the validation study [5].
Conclusion
The prevalence of PHD in an ambulatory adult HIV+
population in Uganda obtained by the IHDS was 64.4%.
Gender, age, CD4 count, use of HAART and a diagnosis
of common mental disorder including major depressive
disorder were not associated with PHD on multivariate
analysis. Only a high stress score index and psychosocial
impairment showed such an association. Clinicians need
to be aware of the high risk of PHD among HIV patients
and to make efforts to objectively and appropriatelydiagnose and manage it. Secondly there is need for more
studies to better understand the relationship between
PHD and stress in HIV populations so as to inform pa-
tient care.
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